3rd June 2020
News Therapeutic Areas Translational Sciences
Sygnature expands capabilities with acquisition of Alderley Oncology
10th May 2018
Blog DMPK Therapeutic Areas
Understanding & Predicting Brain Penetration for CNS-targeted Drugs
14th March 2017
Therapeutic Areas
Keapstone Therapeutics and Sygnature Discovery collaborate to discover new therapies for Parkinson’s and Motor Neuron Disease
1st February 2017
Drug Discovery Therapeutic Areas
Sygnature Discovery, Mironid®, and Peak Proteins Join Forces to Tackle Incurable Kidney Disease, ADPKD
5th October 2016
Drug Discovery Therapeutic Areas
Sygnature Discovery and Viramatix Forge Strategic Alliance for Advancing Anti-Viral Drug Discovery